(NOMD) Nomad Foods - Overview
Sector: Consumer Defensive | Industry: Packaged Foods | Exchange: NYSE (USA) | Market Cap: 1.441m USD | Total Return: -38.3% in 12m
Avg Turnover: 18.9M
EPS Trend: 11.1%
Qual. Beats: 1
Rev. Trend: -6.5%
Qual. Beats: 1
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Nomad Foods Limited (NOMD) is a leading European frozen food company that manufactures and distributes a diverse portfolio of products, including frozen fish, vegetables, poultry, and ready-made meals. Headquartered in the United Kingdom, the company operates through a multi-brand strategy, utilizing well-established regional labels such as Birds Eye, Findus, and iglo to maintain market share across various European territories.
The company operates within the consumer staples sector, specifically the packaged foods industry, which typically exhibits lower price elasticity and stable demand during economic cycles. Nomad Foods utilizes a centralized supply chain model to scale production of frozen goods, a category that benefits from long shelf lives and reduced food waste compared to fresh alternatives. For a more granular look at these fundamentals, consider evaluating the companys valuation metrics on ValueRay.
The business model focuses on both organic growth through product innovation, such as meat substitutes under the Green Cuisine brand, and inorganic growth through the acquisition of dominant local brands. Distribution is primarily managed through large-scale supermarkets and food retail chains, ensuring broad consumer reach in both in-home and out-of-home segments.
- European frozen food volume recovery drives organic revenue growth and market share
- Input cost inflation for fish and vegetables pressures gross profit margins
- Strategic expansion of plant-based Green Cuisine brand accelerates portfolio diversification
- High debt leverage sensitivity to interest rate fluctuations impacts net income
- Consolidation of Adriatic region acquisitions improves operational efficiency and scale economies
| Net Income: 133.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA -1.21 > 1.0 |
| NWC/Revenue: 2.33% < 20% (prev 2.32%; Δ 0.01% < -1%) |
| CFO/TA 0.05 > 3% & CFO 308.6m > Net Income 133.4m |
| Net Debt (2.11b) to EBITDA (343.7m): 6.13 < 3 |
| Current Ratio: 1.06 > 1.5 & < 3 |
| Outstanding Shares: last quarter (142.0m) vs 12m ago -8.27% < -2% |
| Gross Margin: 26.61% > 18% (prev 0.30%; Δ 2.63k% > 0.5%) |
| Asset Turnover: 47.09% > 50% (prev 48.06%; Δ -0.97% > 0%) |
| Interest Coverage Ratio: 2.10 > 6 (EBITDA TTM 343.7m / Interest Expense TTM 111.3m) |
| A: 0.01 (Total Current Assets 1.15b - Total Current Liabilities 1.08b) / Total Assets 6.34b |
| B: 0.20 (Retained Earnings 1.27b / Total Assets 6.34b) |
| C: 0.04 (EBIT TTM 233.6m / Avg Total Assets 6.37b) |
| D: 0.65 (Book Value of Equity 2.48b / Total Liabilities 3.84b) |
| Altman-Z'' = 1.65 = BB |
| DSRI: 1.03 (Receivables 423.4m/423.6m, Revenue 3.00b/3.08b) |
| GMI: 1.12 (GM 26.61% / 29.86%) |
| AQI: 1.01 (AQ_t 0.72 / AQ_t-1 0.72) |
| SGI: 0.98 (Revenue 3.00b / 3.08b) |
| TATA: -0.03 (NI 133.4m - CFO 308.6m) / TA 6.34b) |
| Beneish M = -2.94 (Cap -4..+1) = A |
As of May 27, 2026, the stock is trading at USD 10.21 with a total of 904,482 shares traded.
Over the past week, the price has changed by -0.29%,
over one month by +8.18%,
over three months by -7.67% and
over the past year by -38.30%.
Nomad Foods has received a consensus analysts rating of 4.71. Therefore, it is recommended to buy NOMD.
- StrongBuy: 5
- Buy: 2
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 12.9 | 26.3% |
Market Cap EUR = 1.24b (1.44b USD * 0.859 USD.EUR)
P/E Trailing = 9.8143
P/E Forward = 11.1359
P/S = 0.4822
P/B = 0.4944
P/EG = 1.38
Revenue TTM = 3.00b EUR
EBIT TTM = 233.6m EUR
EBITDA TTM = 343.7m EUR
Long Term Debt = 2.27b EUR (from longTermDebt, last quarter)
Short Term Debt = 35.2m EUR (from shortTermDebt, last quarter)
Debt = 2.39b EUR (from shortLongTermDebtTotal, last quarter) + Leases 89.3m
Net Debt = 2.11b EUR (calculated: Debt 2.39b - CCE 282.5m)
Enterprise Value = 3.35b EUR (1.24b + Debt 2.39b - CCE 282.5m)
Interest Coverage Ratio = 2.10 (Ebit TTM 233.6m / Interest Expense TTM 111.3m)
EV/FCF = 14.71x (Enterprise Value 3.35b / FCF TTM 227.4m)
FCF Yield = 6.80% (FCF TTM 227.4m / Enterprise Value 3.35b)
FCF Margin = 7.58% (FCF TTM 227.4m / Revenue TTM 3.00b)
Net Margin = 4.45% (Net Income TTM 133.4m / Revenue TTM 3.00b)
Gross Margin = 26.61% ((Revenue TTM 3.00b - Cost of Revenue TTM 2.20b) / Revenue TTM)
Gross Margin QoQ = 25.67% (prev 25.57%)
Tobins Q-Ratio = 0.53 (Enterprise Value 3.35b / Total Assets 6.34b)
Interest Expense / Debt = 4.65% (Interest Expense 111.3m / Debt 2.39b)
Taxrate = 18.13% (6.51m / 35.9m)
NOPAT = 191.2m (EBIT 233.6m * (1 - 18.13%))
Current Ratio = 1.06 (Total Current Assets 1.15b / Total Current Liabilities 1.08b)
Debt / Equity = 0.96 (Debt 2.39b / totalStockholderEquity, last quarter 2.50b)
Debt / EBITDA = 6.13 (Net Debt 2.11b / EBITDA 343.7m)
Debt / FCF = 9.27 (Net Debt 2.11b / FCF TTM 227.4m)
Total Stockholder Equity = 2.53b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.09% (Net Income 133.4m / Total Assets 6.34b)
RoE = 5.28% (Net Income TTM 133.4m / Total Stockholder Equity 2.53b)
RoCE = 4.87% (EBIT 233.6m / Capital Employed (Equity 2.53b + L.T.Debt 2.27b))
RoIC = 3.82% (NOPAT 191.2m / Invested Capital 5.01b)
WACC = 4.53% (E(1.24b)/V(3.63b) * Re(5.91%) + D(2.39b)/V(3.63b) * Rd(4.65%) * (1-Tc(0.18)))
Discount Rate = 5.91% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -96.61 | Cagr: -6.30%
[DCF] Terminal Value 73.10% ; FCFF base≈259.2m ; Y1≈227.3m ; Y5≈183.6m
[DCF] Fair Price = 6.00 (EV 2.95b - Net Debt 2.11b = Equity 839.4m / Shares 139.8m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 11.09 | EPS CAGR: 0.62% | SUE: 2.13 | # QB: 1
Revenue Correlation: -6.46 | Revenue CAGR: -0.06% | SUE: 1.07 | # QB: 1
EPS current Quarter (2026-06-30): EPS=0.32 | Chg30d=-12.51% | Revisions=-43% | Analysts=6
EPS next Quarter (2026-09-30): EPS=0.50 | Chg30d=+2.59% | Revisions=+50% | Analysts=6
EPS current Year (2026-12-31): EPS=1.51 | Chg30d=+1.72% | Revisions=+50% | GrowthEPS=-9.0% | GrowthRev=-3.4%
EPS next Year (2027-12-31): EPS=1.64 | Chg30d=+1.60% | Revisions=+56% | GrowthEPS=+8.7% | GrowthRev=+1.9%
[Analyst] Revisions Ratio: +56%